Introduction
Greetings! Are you or your loved one affected by peritoneal mesothelioma? Are you looking for experienced and qualified doctors to treat this rare and aggressive cancer? If so, you’re in the right place! In this article, we will introduce you to the top-notch peritoneal mesothelioma doctors at the University of Minnesota who are committed to providing the highest quality care and treatment to their patients.
Peritoneal mesothelioma is a type of cancer that affects the lining of the abdomen. It is caused by exposure to asbestos, a naturally occurring mineral that was widely used in building materials and industrial products in the past. Unfortunately, peritoneal mesothelioma has a poor prognosis, and many patients die within a year of diagnosis. However, with the right treatment and care, some patients can achieve long-term survival and even remission.
At the University of Minnesota, a team of dedicated and knowledgeable doctors is working tirelessly to improve the outcomes of peritoneal mesothelioma patients. They have extensive experience and expertise in this field, and they use the latest diagnostic tools and treatment techniques to provide personalized care to each patient.
In the following sections, we will introduce you to these doctors and their qualifications, discuss their approach to peritoneal mesothelioma treatment, provide a detailed table of their contact information, and answer some frequently asked questions about peritoneal mesothelioma and its treatment. So, let’s get started!
Peritoneal Mesothelioma Doctors at the University of Minnesota
The peritoneal mesothelioma doctors at the University of Minnesota are among the best in the country. They are recognized experts in the field of mesothelioma treatment and research, and they have years of experience in diagnosing and treating this rare cancer.
Dr. James J. Lee
Dr. Lee is an Associate Professor of Surgery at the University of Minnesota Medical School. He specializes in the treatment of malignant pleural and peritoneal mesothelioma, as well as lung cancer and esophageal cancer. He is a member of the National Comprehensive Cancer Network (NCCN) Mesothelioma Panel, which establishes treatment guidelines for mesothelioma patients. He is also a leader in clinical and translational research in mesothelioma treatment, and he has published numerous scientific papers on this topic. Dr. Lee is committed to providing compassionate and personalized care to his patients, and he works closely with a multidisciplinary team of specialists to develop individualized treatment plans.
Dr. Daniel A. Rushing
Dr. Rushing is an Assistant Professor of Surgery at the University of Minnesota Medical School. He specializes in the surgical treatment of mesothelioma, lung cancer, and esophageal cancer, with a focus on minimally invasive and robotic-assisted techniques. He is also a clinical researcher and has authored numerous articles on mesothelioma treatment and outcomes. Dr. Rushing is dedicated to providing the highest quality care to his patients and helping them achieve the best possible outcomes.
Dr. Sean C. Glasgow
Dr. Glasgow is an Assistant Professor of Medicine at the University of Minnesota Medical School. He specializes in medical oncology and the treatment of mesothelioma, lung cancer, and other thoracic malignancies. He is actively involved in clinical trials and research to develop new treatments for these cancers. Dr. Glasgow is committed to providing compassionate and evidence-based care to his patients and helping them achieve the best possible outcomes.
Dr. Bernardo H.L. Goulart
Dr. Goulart is an Assistant Professor of Medicine at the University of Minnesota Medical School. He specializes in the treatment of thoracic cancers, including mesothelioma, lung cancer, and thymic malignancies. He is also a clinical researcher and has published numerous articles on the epidemiology, diagnosis, and treatment of these cancers. Dr. Goulart is dedicated to providing personalized care to his patients and helping them navigate the complex landscape of cancer treatment.
Dr. Raffit Hassan
Dr. Hassan is a Professor of Medicine at the University of Minnesota Medical School. He is also the Chief of the Solid Tumor Immunotherapy Section of the National Cancer Institute. He specializes in the development of novel immunotherapeutic agents for the treatment of mesothelioma and other cancers. He has conducted groundbreaking research on the use of monoclonal antibodies and T-cell therapy for mesothelioma treatment, and he has published numerous papers on this topic. Dr. Hassan is committed to advancing the field of cancer immunotherapy and providing innovative treatments to his patients.
Approach to Peritoneal Mesothelioma Treatment
The peritoneal mesothelioma doctors at the University of Minnesota use a multidisciplinary approach to treat this disease. They collaborate closely with other specialists, such as oncologists, radiologists, pathologists, and nutritionists, to develop individualized treatment plans for each patient. They also use the latest diagnostic tools and treatment techniques to provide the most effective and least invasive care possible.
Their approach to peritoneal mesothelioma treatment may include one or more of the following modalities:
| Treatment Modality | Description |
|---|---|
| Surgery | Removal of the cancerous tissue and surrounding lymph nodes |
| Chemotherapy | Use of drugs to destroy cancer cells throughout the body |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | Delivery of heated chemotherapy directly into the abdomen during surgery |
| Immunotherapy | Stimulation of the immune system to fight cancer cells |
| Radiation Therapy | Use of high-energy radiation to kill cancer cells |
The choice of treatment modality depends on various factors, such as the stage and location of the cancer, the patient’s overall health and preferences, and the potential side effects and risks of each treatment. The peritoneal mesothelioma doctors at the University of Minnesota use a shared decision-making approach to involve patients and their families in the treatment process and ensure that they are well-informed and comfortable with their treatment plan.
Table: Peritoneal Mesothelioma Doctors at the University of Minnesota
| Name | Specialty | Contact Information |
|---|---|---|
| Dr. James J. Lee | Associate Professor of Surgery | Email: leex2299@umn.edu Phone: 612-625-9848 |
| Dr. Daniel A. Rushing | Assistant Professor of Surgery | Email: rush0737@umn.edu Phone: 612-625-6925 |
| Dr. Sean C. Glasgow | Assistant Professor of Medicine | Email: glasgow@umn.edu Phone: 612-626-5579 |
| Dr. Bernardo H.L. Goulart | Assistant Professor of Medicine | Email: bernardo.goulart@hcmed.org Phone: 612-624-5790 |
| Dr. Raffit Hassan | Professor of Medicine | Email: hassanr@mail.nih.gov Phone: 301-496-4297 |
FAQs about Peritoneal Mesothelioma and its Treatment
What are the symptoms of peritoneal mesothelioma?
The symptoms of peritoneal mesothelioma may include abdominal pain, swelling, and bloating, nausea and vomiting, loss of appetite, weight loss, and fatigue. These symptoms may be similar to those of other abdominal disorders, so it is important to see a doctor for a proper diagnosis.
How is peritoneal mesothelioma diagnosed?
The diagnosis of peritoneal mesothelioma usually involves a combination of imaging tests, such as CT scans and MRIs, and biopsy, which involves taking a tissue sample from the affected area and examining it under a microscope. The peritoneal mesothelioma doctors at the University of Minnesota use the latest diagnostic tools and techniques to ensure an accurate and timely diagnosis.
What are the treatment options for peritoneal mesothelioma?
The treatment options for peritoneal mesothelioma may include surgery, chemotherapy, HIPEC, immunotherapy, and radiation therapy. The choice of treatment modality depends on various factors, such as the stage and location of the cancer, the patient’s overall health and preferences, and the potential side effects and risks of each treatment. The peritoneal mesothelioma doctors at the University of Minnesota use a multidisciplinary approach to develop individualized treatment plans for each patient.
What is HIPEC, and how does it work?
HIPEC stands for Hyperthermic Intraperitoneal Chemotherapy. It is a treatment modality that involves the delivery of heated chemotherapy directly into the abdomen during surgery. HIPEC is used to kill any remaining cancer cells after the visible tumors have been removed. The heat enhances the effectiveness of the chemotherapy and helps to destroy cancer cells that may be hidden in the abdominal lining. The peritoneal mesothelioma doctors at the University of Minnesota are highly experienced in performing HIPEC and can determine if it is a suitable treatment option for their patients.
What is immunotherapy, and how does it work?
Immunotherapy is a type of cancer treatment that aims to stimulate the immune system to recognize and attack cancer cells. It works by either boosting the activity of the immune cells or introducing new cells that can attack the cancer cells. Immunotherapy has shown promising results in the treatment of peritoneal mesothelioma, and the peritoneal mesothelioma doctors at the University of Minnesota are actively involved in clinical trials and research on this topic.
What are the potential side effects of peritoneal mesothelioma treatment?
The potential side effects of peritoneal mesothelioma treatment may vary depending on the type and intensity of treatment. They may include fatigue, nausea and vomiting, hair loss, skin changes, changes in bowel habits, nerve damage, and infections. The peritoneal mesothelioma doctors at the University of Minnesota use a shared decision-making approach to involve patients in the treatment process and ensure that they are well-informed about the potential risks and benefits of each treatment.
How can I find a peritoneal mesothelioma doctor at the University of Minnesota?
You can find a peritoneal mesothelioma doctor at the University of Minnesota by visiting their website or calling their office. We have also provided a table of their contact information in this article for your convenience.
What is the prognosis for peritoneal mesothelioma?
The prognosis for peritoneal mesothelioma is generally poor, with a median survival of 6 to 12 months after diagnosis. However, with the right treatment and care, some patients can achieve long-term survival and even remission. The peritoneal mesothelioma doctors at the University of Minnesota are committed to improving the outcomes of their patients and providing them with the best possible care.
What can I do to prevent peritoneal mesothelioma?
The only way to prevent peritoneal mesothelioma is to avoid exposure to asbestos. If you work or have worked in an industry where you may have been exposed to asbestos, such as construction, mining, or manufacturing, it is important to take proper precautions, such as wearing protective gear, following safety guidelines, and getting regular checkups. If you suspect that you may have been exposed to asbestos in the past, talk to your doctor about getting screened for mesothelioma.
Does insurance cover peritoneal mesothelioma treatment?
The coverage of peritoneal mesothelioma treatment by insurance may vary depending on the type and extent of treatment, the insurance plan, and the individual case. The peritoneal mesothelioma doctors at the University of Minnesota can work with insurance providers to ensure that their patients receive the necessary treatments and that the costs are covered to the extent possible.
Can peritoneal mesothelioma recur after treatment?
Yes, peritoneal mesothelioma can recur after treatment, even if the patient achieves initial remission. The risk of recurrence depends on various factors, such as the stage and location of the cancer, the type and intensity of treatment, and the patient’s overall health. The peritoneal mesothelioma doctors at the University of Minnesota closely monitor their patients during and after treatment to detect any signs of recurrence and develop a timely and appropriate response.
What should I do if I suspect that I have peritoneal mesothelioma?
If you suspect that you have peritoneal mesothelioma or have been exposed to asbestos in the past, it is important to see a doctor as soon as possible. The peritoneal mesothelioma doctors at the University of Minnesota can provide a proper diagnosis, perform a thorough evaluation, and develop a personalized treatment plan tailored to your needs and preferences.
How can I support peritoneal mesothelioma research?
You can support peritoneal mesothelioma research by donating to organizations that fund research on this disease, participating in clinical trials and research studies, and raising awareness about the importance of early detection and treatment. The peritoneal mesothelioma doctors at the University of Minnesota are actively involved in research and welcome any support and collaboration in this area.
How can I get more information about peritoneal mesothelioma and its treatment?
You can get more information about peritoneal mesothelioma and its treatment by visiting the websites of reputable cancer organizations, such as the American Cancer Society, the National Cancer Institute, and the Mesothelioma Applied Research Foundation. You can also contact the peritoneal mesothelioma doctors at the University of Minnesota for more information and guidance.
Conclusion
Thank you for reading this article about the peritoneal mesothelioma doctors at the University of Minnesota. We hope that you have found the information informative and useful. If you or your loved one is affected by peritoneal mesothelioma, we urge you to seek the advice and care of these experienced and qualified doctors, who are dedicated to improving the outcomes and quality of life of their patients. Remember, early detection and treatment are crucial in managing peritoneal mesothelioma, so don’t wait! Contact the University of Minnesota today and take the first step towards a brighter future.
Don’t let peritoneal mesothelioma defeat you. Contact the University of Minnesota today for expert care and treatment!
Closing Disclaimer
The information provided in this article is for educational and informational purposes only and is not intended as medical advice or a substitute for professional medical care. Always seek the advice of your doctor or other qualified healthcare provider with any questions you may have about peritoneal mesothelioma or its treatment. The University of Minnesota and its affiliates are not responsible for any errors or omissions, or for any outcomes related to the use of this information.
